Enterohaemorrhagic Escherichia coli produces outer membrane vesicles as an active defence system against antimicrobial peptide LL-37.
Urashima. Akiko A; Sanou. Ayano A; Yen. Hilo H; Tobe. Toru T
Key Findings
- Butyrate (a short‑chain fatty acid) boosts EHEC resistance to LL‑37 by activating the ompT gene.
- Instead of making more OmpT enzyme inside the cell, EHEC packs OmpT into outer membrane vesicles (OMVs) that are released into the environment.
- Sub‑lethal amounts of LL‑37 itself trigger more OMV production, and OMVs from OmpT‑positive strains can protect even OmpT‑negative bacteria from LL‑37.
Practical Outcomes
- For biohackers considering LL‑37 as a gut‑health or antimicrobial supplement, this research suggests bacteria can neutralize it, limiting its effectiveness. It highlights the importance of understanding bacterial defense mechanisms before using AMPs therapeutically. No direct protocol changes are recommended based on this study.
Summary
The study shows that a harmful gut bacterium (EHEC) can protect itself from the human antimicrobial peptide LL‑37 by releasing tiny vesicles loaded with a protein (OmpT). These vesicles soak up LL‑37, making the bacteria more resistant, especially when the bacteria are also turning on other disease‑related genes.
Abstract
Antimicrobial peptides (AMPs) are important components of the innate immune system. Enterohaemorrhagic Escherichia coli (EHEC), a food-borne pathogen causing serious diarrheal diseases, must overcome attack by AMPs. Here, we show that resistance of EHEC against human cathelicidin LL-37, a primary AMP, was enhanced by butyrate, which has been shown to act as a stimulant for the expression of virulence genes. The increase of resistance depended on the activation of the ompT gene, which encodes the outer membrane protease OmpT for LL-37. The expression of the ompT gene was enhanced through the activation system for virulence genes. The increase in ompT expression did not result in an increase in OmpT protease in bacteria but in enhancement of the production of OmpT-loaded outer membrane vesicles (OMVs), which primarily contributed to the increase in LL-37-resistance. Furthermore, a sublethal dosage of LL-37 stimulated the production of OMVs. Finally, we showed that OMVs produced by OmpT-positive strains protect the OmpT-negative strain, which is susceptible to LL-37 by itself more efficiently than OMVs from the ompT mutant. These results indicate that EHEC enhances the secretion of OmpT-loaded OMVs in coordination with the activation of virulence genes during infection and blocks bacterial cell attack by LL-37.
Study Information
pubmed
2017
2017-07-06T00:00:00.000Z
10.1111/cmi.12758
31
37